Viking Therapeutics
VKTX
$76.97
Share price
1.60%
Change (1 day)
236.70%
Change (1 year)
Categories
Viking Therapeutics (VKTX) - Cash on Hand
Cash on Hand as of March 2024 : $0.96 B
According to Viking Therapeutics
's latest financial reports the company has $0.96 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Viking Therapeutics - Cash on Hand chart (from 2014 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.36 B | 132.87% |
| 2022-12-31 | $0.15 B | -23.07% |
| 2021-12-31 | $0.20 B | -18.63% |
| 2020-12-31 | $0.24 B | -9.89% |
| 2019-12-31 | $0.27 B | -8.58% |
| 2018-12-31 | $0.30 B | 1365.47% |
| 2017-12-31 | $20.57 M | 56.46% |
| 2016-12-31 | $13.15 M | -6.76% |
| 2015-12-31 | $14.1 M | 1765.97% |
| 2014-12-31 | $0.75 M | 320.81% |
| 2013-12-31 | $0.17 M | |
| 2012-12-31 | $N/A |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Ultragenyx RARE | $0.57 B | -40.06% | 🇺🇸 USA |
 Repligen
RGEN | $0.75 B | -21.98% | 🇺🇸 USA |
 Recro Pharma
REPH | N/A | N/A | 🇺🇸 USA |